A study by UC San Diego researchers and their colleagues has found that semaglutide slows down the accumulation of biological aging markers in the DNA of adults with HIV, pointing to the potential of GLP?1 receptor agonists to help prevent age?related diseases.
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
